Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Gender, Racial, and Fitzpatrick Skin Type Representation in Melasma Clinical Trials

By Chuck Lin No Comments
INTRODUCTIONMelasma, a symmetric pigmentary disorder, develops primarily on the face.1 Melasma typically presents as light brown to dark brown macules and patches on the forehead, malar region, and chin.1 Melasma…
Read More
Dec 09
Love0

Social Media’s Impact on Hair Loss Information Dissemination: A Systematic Review

By Chuck Lin No Comments
INTRODUCTIONThe internet has become a widely used source for health information, including hair loss. Social media platforms, interactive digital applications where users generate and share content, have also become important…
Read More
Dec 01
Love0

FULL SUPPLEMENT: United States Cutaneous Oncodermatology Management (Uscom) Iv: A Multidisciplinary-Guided Algorithm For Preventing And Managing Cutaneous Targeted Therapy-Related Adverse Events In Cancer Patients

By Chuck Lin No Comments
In this supplement: USCOM IV Algorithm for the Prevention and Management of Targeted Therapy-Related Cutaneous Adverse Events In 2023, an estimated 1,958,310 Americans were diag-nosed with cancer.1 Although overall incidence con-tinues…
Read More
Nov 30
Love0

Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris is one of the most common dermatologic disorders worldwide.1 This inflammatory condition most frequently affects adolescents, where it can develop rapidly and present as more severe disease compared…
Read More
Nov 30
Love0

Effective With Minimal Side Effects: A Novel Treatment Regimen for Acne Vulgaris Using Multifunctional Ingredients

By Chuck Lin No Comments
INTRODUCTIONAcne is the most common dermatologic condition. According to the American Academy of Dermatology, acne affects 50 million Americans annually, and 85% of people aged 12 to 24 experience at…
Read More
Nov 30
Love0

Pharmacological Complications in Ocular Dermatology: A Review and Update

By Chuck Lin No Comments
INTRODUCTIONPeriorbital skin is unique in its anatomical nature, distinguishing it from skin in other parts of the body. With periocular skin thinner than 1 to 2 mm and eyelids less…
Read More
Nov 30
Love0

Laser and Energy Treatments for Acne Scarring: A Review of Clinical Trials

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris is a common chronic inflammatory disease of the pilosebaceous unit that can lead to permanent scarring, leaving the face disfigured and negatively impacting one’s quality of life.1 Acne-related…
Read More
Nov 29
Love0

International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting

By Chuck Lin No Comments
INTRODUCTIONThe International Dermatology Outcome Measures (IDEOM) initiative is a non-profit organization founded in 2013 to enhance research and treatment of dermatologic disease by addressing a need for validated, standardized, patient-centered…
Read More
Nov 29
Love0

The Role of JAK Inhibitors in the Treatment of Cutaneous Lupus Erythematosus: A Review

By Chuck Lin No Comments
INTRODUCTIONLupus erythematosus (LE) is a chronic autoimmune disease with multisystem organ involvement and is characterized by a broad spectrum of clinical, immunologic, and histologic manifestations. This condition most commonly affects…
Read More
Nov 26
Love0

Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study

By Chuck Lin No Comments
INTRODUCTIONNon-melanoma skin cancers, comprising primarily of cutaneous basal (BCC) and squamous cell carcinomas (SCC), present a significantly higher mortality and morbidity risk in patients with skin of color as compared…
Read More
Nov 25
Love0

Novel Methods in Acne Treatment and Skin Care: A Review

By Chuck Lin No Comments
INTRODUCTIONThe skin is colonized by commensal skin microbes that live in homeostasis with the host to form a resident microbiome, and temporarily live on the skin pathogen microbes from the…
Read More
Nov 25
Love0

A Novel Four-Step Regimen is Efficacious in Improving Uneven Skin Tone in Sensitive Skin Patients

By Chuck Lin No Comments
INTRODUCTIONUneven skin tone is a significant beauty concern for individuals across all types of Fitzpatrick skin types and ethnic heritages, although it may be a more prominent concern for those…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • What’s Old is New: The Translational Understanding of and Approaches to Dermatoporosis May 13, 2025
  • Safety of Topical Dermatologic Medications in Pregnancy: What You Need to Know May 12, 2025
  • Successful Treatment of Sacral Pressure Injury With ACU-D1 May 10, 2025
  • Decoding Derm: What’s the Diagnosis? National Melonoma and Skin Cancer Awareness Month May 9, 2025
  • JDD Article on HA Fillers Gets a Beauty Spotlight—Here’s Why Dermatologists Should Take Note May 8, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search